Kloramfenikol Santen (Chloramphenicol)

Chloramphenicol interferes with bacterial protein synthesis by binding to the 50S subunit of the ribosome. This blocks peptide chain formation, halting bacterial growth and providing a bacteriostatic effect against susceptible ocular pathogens.

The dosing regimen for Kloramfenikol Santen is determined by the prescribing clinician based on the type and severity of the infection, patient age and response to therapy. The prescriber will specify the number of drops, frequency and duration of treatment.

Safety data for chloramphenicol eye drops in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified health professional.

To place an order, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Chloramphenicol offers broad‑spectrum activity against many Gram‑positive and Gram‑negative bacteria and is often used when resistance to fluoroquinolones or macrolides is a concern. Unlike some newer agents, it is bacteriostatic rather than bactericidal and may have a different safety profile, particularly regarding rare systemic toxicity.

Store the product at temperatures below 25 °C, in its original container, protected from moisture and direct light. Do not freeze. Keep out of reach of children and avoid exposure to excessive heat or humidity.

The eye drops are applied directly to the affected eye(s) as directed by the prescriber, typically by pulling down the lower eyelid and instilling the prescribed number of drops. Hands should be washed before use, and the dropper tip should not touch the eye or any surface.

Serious adverse events include aplastic anemia, severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome and other severe skin reactions, as well as visual loss unrelated to infection. Any signs of systemic toxicity, unexplained bruising, or severe eye discomfort should prompt immediate medical evaluation.

Patients with a known hypersensitivity to chloramphenicol or any component of the formulation should avoid its use. It is also contraindicated for viral, fungal or non‑infectious inflammatory eye conditions, and should be used with caution in individuals with a history of bone‑marrow disorders.